Zymeworks ZYME 深 沪
等待开盘 08-20 09:30:00 美东时间
27.21
+1.140
+4.37%
华盛通- 最 高27.8326
- 今 开27.12
- 成交量 84.52万股
- 最 低 26.365
- 昨 收 26.07
- 总市值 19.31亿
- 52周最高 29.75
- 市盈率 静 --
- 换手率 1.19%
- 52周最低 13.60
- 委 比 36.91%
- 总股本 7095.92万
- 历史最高 59.03
- 量 比 1.59
- 振 幅 5.63%
- 历史最低 4.11
- 每 手 1
- 风险率 3.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks Inc. announced that its management will participate in several upcoming investor conferences in September 2026. These include the Wells Fargo Healthcare Conference in Boston on September 8, the Citi’s Biopharma Back to School Summit in New York on September 9, the Morgan Stanley Healthcare Conference in New York on September 14, and the H.C. Wainwright Annual Global Investment Conference in New York on September 15. Zymeworks is a globa...
08-11 10:00
Zymeworks gains following addition to Citi catalyst watch
Zymeworks (ZYME) is up ~2% in Monday trading after Citi added the stock to its 90-day catalyst watch list. The bank sees shares rising due to an August 25 FDA action date for zanidatamab, sold as Ziih...
08-11 00:05
Zymeworks Posts Strong Q2 Results, Highlights Growth Catalysts
Zymeworks ( ($ZYME) ) just unveiled an announcement. Zymeworks reported its sec...
08-07 04:59
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
HC Wainwright & Co. Maintains Buy on Zymeworks, Raises Price Target to $51
HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $46 to $51.
08-06 01:49
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
Dyadic International announced the expansion of its bio-industrial pipeline with a new proprietary enzyme program for advanced cellulose processing, building on the success of EN3ZYME™ and demonstrating the scalability of its Dapibus™ platform. The program targets applications like pulp biorefining and cellulose production, addressing a multi-billion-dollar market for sustainable industrial enzyme solutions. Dyadic plans to commercialize the enzy...
07-16 12:00
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
Zymeworks Inc. announced it will report its second quarter 2026 financial results on August 6, 2026, after market close. Due to the proposed acquisition of Theravance Biopharma, the company will not host a second quarter earnings conference call. Zymeworks, a global biotechnology company, focuses on managing licensed healthcare assets and developing innovative biotherapeutics for diseases like cancer, inflammation, and autoimmune disorders. The c...
07-16 10:00
美股大行评级 | 最高800美元！16家大行首予SpaceX"买入"或"超配"评级；奥本海上调康宁目标价从210美元升至230美元
今日重点评级关注：Canaccord Genuity：维持AtaiBeckley"买入"评级，目标价从15美元升至17美元；Truist Securities：维持NUVATION BIO"买入"评级，目标价从12美元升至13美元
07-08 15:31
